BillionToOne, Inc. BLLN

Annual Quarterly

FY2025 · ended Dec 31, 2025 · Revenue $305.11M · Filed Mar 11, 2026

BillionToOne, Inc. (BLLN) files with the SEC under industry code 8071, Services-Medical Laboratories. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $305.1 million and net income of $7.5 million. Free cash flow was $15.7 million. As of Sep 30, 2026 it held $561.5 million in cash and investments and $140.4 million in total debt.

Revenue (TTM)
$436.87M
Net income (TTM)
$49.39M
Operating cash flow (TTM)
$47.91M
Free cash flow (TTM)
$33.90M
EPS (TTM)
$0.92
Dividend per share
None
Shares outstanding
—
Net cash
$421.06M
as of Sep 30, 2026
Operating margin
10.2%
FY 2026

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
BLLN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Menlo Park, CA
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
2070849

Other Services-Medical Laboratories companies

All 29 Services-Medical Laboratories companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

FY 2025
Dec 31, 2025
Revenue
$305.1M
Operating income
$16.0M
Net income
$7.5M
Diluted EPS
$0.14
Operating cash flow
$24.6M
Free cash flow
$15.7M
Total assets
$632.7M
Total liabilities
$152.5M
Stockholders' equity
$480.1M
Cash and investments
$496.0M
Total debt
$108.9M

Recent SEC filings

Form Description Filed Period
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Results of operations
 Nov 4, 2026 Nov 4, 2026
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations
 Aug 5, 2026 Aug 5, 2026
8-K Current report
Material agreement, New debt
 Jun 29, 2026 Jun 23, 2026
8-K Current report
Material agreement, New debt
 Jun 16, 2026 Jun 10, 2026

All 178 BillionToOne, Inc. SEC filings

Source: SEC EDGAR filings. This is company-reported data, not investment advice.